Atlas Trials

API-CAT STUDY for APIxaban Cancer Associated Thrombosis

Clinical trial NCT03692065 · COMPLETED

Trial details

NCT number
NCT03692065
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cancer-associated Thrombosis
Start date
2018-10-11
Primary completion
2024-09-06
Enrollment
1766

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.